Akari Therapeutics PLC (AKTX)

2.08 -0.15 (-6.73%) USD  |  NASDAQ  |  Nov 15, 16:00
2.01 -0.07 (-3.37%) After-Hours: 20:00
More

Akari Therapeutics Commercial Paper Liability (Quarterly)

Commercial Paper Liability (Quarterly) Chart

View Commercial Paper Liability (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Commercial Paper Liability (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Commercial Paper Liability (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Quarterly) Benchmarks

DBV Technologies SA --
Cellectis SA --
Adaptimmune Therapeutics PLC --
Biodexa Pharmaceuticals PLC --
NuCana PLC --